In accordance with our findings, a double-blind randomized clinical trial showed that the administration of high doses of VITD in obese patients with peripheral insulin resistance or pre-DM increased the sensitivity to insulin and reduced the chance of progression of the condition to DM [30]. Here, INS is linked to Insulin resistance.